New strategy to attack aggressive brain cancer shows promise
Time:2024-05-21 20:39:08 Source:businessViews(143)
WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Previous:Iran helicopter crash that killed President Raisi could reverberate across the Middle East
Next:Colton Herta shows speed as Honda fights back in penultimate Indy 500 practice session
You may also like
- Abbey Clancy, 38, shows off a new set of train track braces as she's left red
- Outfielder Tommy Pham returns to major leagues with the MLB
- Closing prices for crude oil, gold and other commodities
- Rory McIlroy and Shane Lowry remain tied for lead in the Zurich Classic of New Orleans
- Ship that caused Baltimore bridge collapse has been refloated
- Australia's Grace Kim opens 4
- FM spokesperson refutes western accusation of overcapacity
- Brewers left
- Analysis: Larson enters conversation with Verstappen as best drivers in the world